These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11689208)

  • 21. Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis.
    Bruce C; Tall AR
    Curr Opin Lipidol; 1995 Oct; 6(5):306-11. PubMed ID: 8520853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteryl ester efflux from extracellular and cellular elements of the arterial wall. Model systems in culture with cholesteryl linoleyl ether.
    Stein O; Halperin G; Stein Y
    Arteriosclerosis; 1986; 6(1):70-8. PubMed ID: 3942561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
    Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis.
    Rittershaus CW; Miller DP; Thomas LJ; Picard MD; Honan CM; Emmett CD; Pettey CL; Adari H; Hammond RA; Beattie DT; Callow AD; Marsh HC; Ryan US
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2106-12. PubMed ID: 10978256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
    El Khoury P; Waldmann E; Huby T; Gall J; Couvert P; Lacorte JM; Chapman J; Frisdal E; Lesnik P; Parhofer KG; Le Goff W; Guerin M
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):285-94. PubMed ID: 26681758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is reverse cholesterol transport a misnomer for suggesting its role in the prevention of atheroma formation?
    Quintão EC
    Atherosclerosis; 1995 Jul; 116(1):1-14. PubMed ID: 7488324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients.
    Kimura H; Miyazaki R; Suzuki S; Gejyo F; Yoshida H
    Am J Kidney Dis; 2001 Jul; 38(1):70-6. PubMed ID: 11431184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins.
    Ishigami M; Yamashita S; Sakai N; Arai T; Hirano K; Hiraoka H; Kameda-Takemura K; Matsuzawa Y
    J Biochem; 1994 Aug; 116(2):257-62. PubMed ID: 7822240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular disorders of cholesteryl ester transfer protein.
    Yamashita S; Arai T; Hirano K; Sakai N; Ishigami M; Nakajima N; Matsuzawa Y
    J Atheroscler Thromb; 1996; 3(1):1-11. PubMed ID: 9225233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis.
    O'Brien KD; Vuletic S; McDonald TO; Wolfbauer G; Lewis K; Tu AY; Marcovina S; Wight TN; Chait A; Albers JJ
    Circulation; 2003 Jul; 108(3):270-4. PubMed ID: 12835223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport.
    Tchoua U; D'Souza W; Mukhamedova N; Blum D; Niesor E; Mizrahi J; Maugeais C; Sviridov D
    Cardiovasc Res; 2008 Mar; 77(4):732-9. PubMed ID: 18056760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
    Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
    Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
    Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Cholesteryl Ester Transfer Protein Increases Macrophage-Derived Foam Cell Accumulation in Atherosclerotic Lesions of Transgenic Rabbits.
    Gao S; Wang X; Cheng D; Li J; Li L; Ran L; Zhao S; Fan J; Liu E
    Mediators Inflamm; 2017; 2017():3824276. PubMed ID: 29317793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice.
    MacLean PS; Bower JF; Vadlamudi S; Osborne JN; Bradfield JF; Burden HW; Bensch WH; Kauffman RF; Barakat HA
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1412-5. PubMed ID: 12791674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits.
    Okamoto H; Yonemori F; Wakitani K; Minowa T; Maeda K; Shinkai H
    Nature; 2000 Jul; 406(6792):203-7. PubMed ID: 10910363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.
    Tall A; Sammett D; Granot E
    J Clin Invest; 1986 Apr; 77(4):1163-72. PubMed ID: 3958185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levels.
    Scharnagl H; Heuschneider C; Sailer S; Kleber ME; März W; Ritsch A
    Eur J Clin Invest; 2014 Apr; 44(4):395-401. PubMed ID: 24467215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pros and cons of inhibiting cholesteryl ester transfer protein.
    Hirano K; Yamashita S; Matsuzawa Y
    Curr Opin Lipidol; 2000 Dec; 11(6):589-96. PubMed ID: 11086331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia.
    de Grooth GJ; Smilde TJ; Van Wissen S; Klerkx AH; Zwinderman AH; Fruchart JC; Kastelein JJ; Stalenhoef AF; Kuivenhoven JA
    Atherosclerosis; 2004 Apr; 173(2):261-7. PubMed ID: 15064100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.